Who owns the ABRIVI THERAPEUTICS trademark?

The ABRIVI THERAPEUTICS trademark is owned by LYKOS THERAPEUTICS, INC..

What is the serial number for ABRIVI THERAPEUTICS?

The USPTO serial number for ABRIVI THERAPEUTICS is 98341186.

What is the registration number for ABRIVI THERAPEUTICS?

ABRIVI THERAPEUTICS is registered under USPTO registration number 0.

ABR

USPTO Trademark Record

ABANDONED

ABRIVI THERAPEUTICS

Q: What class is the ABRIVI THERAPEUTICS trademark registered in?

The ABRIVI THERAPEUTICS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 98341186·Reg 0·Filed Jan 04, 2024

Owner LYKOS THERAPEUTICS, INC.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

ABRIVI THERAPEUTICS (Serial No. 98341186), Registration No. 0, is a abandoned US trademark filed on Jan 04, 2024 by LYKOS THERAPEUTICS, INC.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

ABRIVI THERAPEUTICS (Reg. #0) is an abandoned US trademark that was filed in 2024 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs....

FILED

Jan 04, 2024

SERIAL

98341186

REG#

Owner

Applicant

LYKOS THERAPEUTICS, INC.

Entity

Corporation

State

Address

1 LINCOLN ST, 31ST FLOOR, BOSTON, MA, 02111

Country

Attorney

NameKaren Won

Law firm

Karen Won Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C.

Docket

061786-400

Address

One Financial Center, Boston, MA 02111, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateJan 04, 2024

Serial Number98341186

Registration No.0

Status DateApr 28, 2025

Mark TypeStandard characters

Attorney Docket061786-400

Status DescriptionDead and abandoned due to failure to respond

Filing Signals

FILED

2024

YEARS AGO

CLASSES

MADRID FILINGS

—

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

13 events

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Apr 28, 2025

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Apr 28, 2025

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Jan 07, 2025

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Jan 07, 2025

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

NON-FINAL ACTION WRITTEN

Oct 10, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Oct 10, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 10, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Sep 23, 2024

ASSIGNED TO EXAMINER

Aug 07, 2024

ASSIGNED TO EXAMINER

Jul 31, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 21, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Apr 03, 2024

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

NEW APPLICATION ENTERED

Jan 04, 2024

NEW APPLICATION ENTERED

ABRIVI THERAPEUTICS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by LYKOS THERAPEUTICS, INC.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Karen Won

Resources

Company